Smoking and Cognition in Parkinson’s disease

Title of the study: Neuropsychological profiles of the patients exposed and non exposed to smoke in idiopatic Parkinson’s disease

Principal  Investigator: Martine Simard, PhD,

Co-investigators: Maxime Doiron, B.A., Nicolas Dupré, M.D., M.Sc., Mélanie Langlois, M.D and Michel Panisset, M.D.

Site of the study: CHU ― Hôpital de l’Enfant-Jésus, 1401, 18e rue, Québec, Québec, G1J 1Z4

CHUM ― Hôpital Notre-Dame, 1560 Sherbrooke Street East, Montréal, QC H2L 4M1

Abstract: There is little knowledge about the risk factors predisposing to cognitive impairments disorders and dementia in Parkinson’s disease , despite their high frequency and considerable impact on of patients quality of life and survival.  Smoking is a habit that can lead to problems with intellectual functions. However, the association between smoking and intellectual fuctioning is not yet determined.

Objective: The purpose of the study is to better understand the association between smoking and secondhand smoke, intellectual functioning and psychological symptoms in Parkinson’s disease.